84 related articles for article (PubMed ID: 7883289)
1. Potassium channel blockade amplifies cardiac instability numerical studies of torsades de pointes.
Starmer CF; Reddy MR; Namasivayam A; Singh M
Indian J Physiol Pharmacol; 1994 Oct; 38(4):259-66. PubMed ID: 7883289
[TBL] [Abstract][Full Text] [Related]
2. [Ion channels and arrhythmias].
Borchard U; Hafner D
Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
4. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
Cimponeriu A; Starmer CF; Bezerianos A
IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
[TBL] [Abstract][Full Text] [Related]
5. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
Calderone V; Cavero I
Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].
Kecskeméti V
Neuropsychopharmacol Hung; 2004 Mar; 6(1):5-12. PubMed ID: 15125308
[TBL] [Abstract][Full Text] [Related]
7. Role of potassium currents in cardiac arrhythmias.
Ravens U; Cerbai E
Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
[TBL] [Abstract][Full Text] [Related]
8. In silico risk assessment for drug-induction of cardiac arrhythmia.
Suzuki S; Murakami S; Tsujimae K; Findlay I; Kurachi Y
Prog Biophys Mol Biol; 2008 Sep; 98(1):52-60. PubMed ID: 18635251
[TBL] [Abstract][Full Text] [Related]
9. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
[TBL] [Abstract][Full Text] [Related]
10. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing.
Fish JM; Di Diego JM; Nesterenko V; Antzelevitch C
Circulation; 2004 May; 109(17):2136-42. PubMed ID: 15078801
[TBL] [Abstract][Full Text] [Related]
11. Proarrhythmic response to potassium channel blockade. Numerical studies of polymorphic tachyarrhythmias.
Starmer CF; Romashko DN; Reddy RS; Zilberter YI; Starobin J; Grant AO; Krinsky VI
Circulation; 1995 Aug; 92(3):595-605. PubMed ID: 7634474
[TBL] [Abstract][Full Text] [Related]
12. [Current classification of anti-arrhythmia agents].
Weirich J; Wenzel W
Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
[TBL] [Abstract][Full Text] [Related]
13. A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium.
Nesterenko VV; Lastra AA; Rosenshtraukh LV; Starmer CF
J Cardiovasc Pharmacol; 1992 May; 19(5):810-20. PubMed ID: 1381780
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of cardiac potassium channels.
Tamargo J; Caballero R; Gómez R; Valenzuela C; Delpón E
Cardiovasc Res; 2004 Apr; 62(1):9-33. PubMed ID: 15023549
[TBL] [Abstract][Full Text] [Related]
15. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
Milberg P; Pott C; Eckardt L; Breithardt G
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the proarrhythmic potential of QT-prolonging drugs.
Wolbrette D
Curr Womens Health Rep; 2002 Apr; 2(2):105-9. PubMed ID: 12116598
[TBL] [Abstract][Full Text] [Related]
17. [Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].
Fazekas T; Liszkai G
Orv Hetil; 2005 Mar; 146(10):451-60. PubMed ID: 15835343
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.
Calderone V; Testai L; Martinotti E; Del Tacca M; Breschi MC
J Pharm Pharmacol; 2005 Feb; 57(2):151-61. PubMed ID: 15720777
[TBL] [Abstract][Full Text] [Related]
19. [Torsades de pointes].
Guize L; Iliou MC; Bayet G; Lavergne T; Le Heuzey JY
Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):769-76. PubMed ID: 8267505
[TBL] [Abstract][Full Text] [Related]
20. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
